Chiron Behring GmbH & Co. KG; est. no. 1222

Chiron Behring GmbH & Co. KG - P.O. Box 1630, 35006 Marburg, Germany; formerly a subsidiary of Hoechst AG; Chiron Corp. acquired 49% of Behringwerke AG from Hoechst Marion Roussel (Hoechst AG) in July 1996, forming Chiron Behring which operated as a joint venture of Chiron and Hoechst Marion Roussel; Chiron purchased the remaining 51% in April 1998; Novartis AG acquired Chiron in late 2005.

Related product monographs:

1. tPA, rDNA/Genentech -- Europe mark.
2. Diphtheria & Tetanus Toxoids, conc. -- Manuf. ; R&D ; Tech.
3. DTaP Vaccine/GSK -- Manuf. ; R&D ; Tech.
4. DTaP Vaccine/NAVA -- Europe mark. ; Former
5. dTpa booster/GSK -- Manuf. other
6. DTaP-HBV, rDNA-IPV/GSK -- Manuf. other
7. Rabies Vaccine/Novartis -- Former
8. Typhoid Vaccine/Berna -- Former

Location - Marburg 35006 Germany For

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute